Búsqueda | Portal de Búsqueda de la BVS España

1.

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Schuster, Stephen J; Svoboda, Jakub; Chong, Elise A; Nasta, Sunita D; Mato, Anthony R; Anak, Özlem; Brogdon, Jennifer L; Pruteanu-Malinici, Iulian; Bhoj, Vijay; Landsburg, Daniel; Wasik, Mariusz; Levine, Bruce L; Lacey, Simon F; Melenhorst, Jan J; Porter, David L; June, Carl H.

N Engl J Med; 377(26): 2545-2554, 2017 12 28.

Artículo en Inglés | MEDLINE | ID: mdl-29226764

2.

Neurotoxicity after CTL019 in a pediatric and young adult cohort.

Gofshteyn, Jacqueline S; Shaw, Pamela A; Teachey, David T; Grupp, Stephan A; Maude, Shannon; Banwell, Brenda; Chen, Fang; Lacey, Simon F; Melenhorst, Jan J; Edmonson, MacKenzie J; Panzer, Jessica; Barrett, David M; McGuire, Jennifer L.

Ann Neurol; 84(4): 537-546, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-30178481

3.

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.

Bhoj, Vijay G; Arhontoulis, Dimitrios; Wertheim, Gerald; Capobianchi, James; Callahan, Colleen A; Ellebrecht, Christoph T; Obstfeld, Amrom E; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Hwang, Wei-Ting; Maude, Shannon L; Wasik, Mariusz A; Bagg, Adam; Schuster, Stephen; Feldman, Michael D; Porter, David L; Grupp, Stephen A; June, Carl H; Milone, Michael C.

Blood; 128(3): 360-70, 2016 07 21.

Artículo en Inglés | MEDLINE | ID: mdl-27166358

4.

Chimeric antigen receptor T cells for sustained remissions in leukemia.

Maude, Shannon L; Frey, Noelle; Shaw, Pamela A; Aplenc, Richard; Barrett, David M; Bunin, Nancy J; Chew, Anne; Gonzalez, Vanessa E; Zheng, Zhaohui; Lacey, Simon F; Mahnke, Yolanda D; Melenhorst, Jan J; Rheingold, Susan R; Shen, Angela; Teachey, David T; Levine, Bruce L; June, Carl H; Porter, David L; Grupp, Stephan A.

N Engl J Med; 371(16): 1507-17, 2014 Oct 16.

Artículo en Inglés | MEDLINE | ID: mdl-25317870

5.

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.

Melenhorst, Jan J; Castillo, Paul; Hanley, Patrick J; Keller, Michael D; Krance, Robert A; Margolin, Judith; Leen, Ann M; Heslop, Helen E; Barrett, A John; Rooney, Cliona M; Bollard, Catherine M.

Mol Ther; 23(1): 179-83, 2015 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-25266309

6.

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights.

Obstfeld, Amrom E; Frey, Noelle V; Mansfield, Keith; Lacey, Simon F; June, Carl H; Porter, David L; Melenhorst, Jan J; Wasik, Mariusz A.

Blood; 130(23): 2569-2572, 2017 12 07.

Artículo en Inglés | MEDLINE | ID: mdl-29074500

7.

KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

Zhao, Ling; Melenhorst, Jan J; Alemu, Lemlem; Kirby, Martha; Anderson, Stacie; Kench, Maggie; Hoogstraten-Miller, Shelley; Brinster, Lauren; Kamikubo, Yasuhiko; Gilliland, D Gary; Liu, P Paul.

Blood; 119(6): 1511-21, 2012 Feb 09.

Artículo en Inglés | MEDLINE | ID: mdl-22160378

8.

Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

McIver, Zachariah A; Melenhorst, Jan J; Grim, Andrew; Naguib, Nicholas; Weber, Gerrit; Fellowes, Vicki; Khuu, Hahn; Stroncek, David S; Leitman, Susan F; Battiwalla, Minoo; Barrett, A John.

Biol Blood Marrow Transplant; 17(12): 1846-54, 2011 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-21684345

9.

The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.

Scheinberg, Phillip; Melenhorst, Jan J; Brenchley, Jason M; Hill, Brenna J; Hensel, Nancy F; Chattopadhyay, Pratip K; Roederer, Mario; Picker, Louis J; Price, David A; Barrett, A John; Douek, Daniel C.

Blood; 114(24): 5071-80, 2009 Dec 03.

Artículo en Inglés | MEDLINE | ID: mdl-19776383

10.

Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy.

Rubin, Courtney B; Elenitsas, Rosalie; Taylor, Laura; Lacey, Simon F; Kulikovskaya, Irina; Gupta, Minnal; Melenhorst, Jan J; Loren, Alison; Frey, Noelle; June, Carl H; Porter, David; Rosenbach, Misha.

J Am Acad Dermatol; 75(5): 1054-1057, 2016 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-27745631

11.

When one is better than two.

Melenhorst, Jan J.

Cytotherapy; 15(2): 139, 2013 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-23321324

12.

The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements.

Scheinberg, Phillip; Melenhorst, Jan J; Hill, Brenna J; Keyvanfar, Keyvan; Barrett, A John; Price, David A; Douek, Daniel C.

J Immunol Methods; 321(1-2): 107-20, 2007 Apr 10.

Artículo en Inglés | MEDLINE | ID: mdl-17316678

13.

Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer.

Melenhorst, Jan J; Lacey, Simon F; Bedoya, Felipe.

Curr Drug Targets; 18(3): 332-340, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-26302796

14.

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

O'Rourke, Donald M; Nasrallah, MacLean P; Desai, Arati; Melenhorst, Jan J; Mansfield, Keith; Morrissette, Jennifer J D; Martinez-Lage, Maria; Brem, Steven; Maloney, Eileen; Shen, Angela; Isaacs, Randi; Mohan, Suyash; Plesa, Gabriela; Lacey, Simon F; Navenot, Jean-Marc; Zheng, Zhaohui; Levine, Bruce L; Okada, Hideho; June, Carl H; Brogdon, Jennifer L; Maus, Marcela V.

Sci Transl Med; 9(399)2017 07 19.

Artículo en Inglés | MEDLINE | ID: mdl-28724573

15.

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy.

Chen, Fang; Teachey, David T; Pequignot, Edward; Frey, Noelle; Porter, David; Maude, Shannon L; Grupp, Stephan A; June, Carl H; Melenhorst, Jan J; Lacey, Simon F.

J Immunol Methods; 434: 1-8, 2016 07.

Artículo en Inglés | MEDLINE | ID: mdl-27049586

16.

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Perazzelli, Jessica; Klichinsky, Michael; Aikawa, Vania; Nazimuddin, Farzana; Kozlowski, Miroslaw; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Morrissette, Jennifer J D; Christian, David A; Hunter, Christopher A; Kalos, Michael; Porter, David L; June, Carl H; Grupp, Stephan A; Gill, Saar.

J Clin Invest; 126(10): 3814-3826, 2016 10 03.

Artículo en Inglés | MEDLINE | ID: mdl-27571406

17.

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.

Grube, Matthias; Rezvani, Katayoun; Wiestner, Adrian; Fujiwara, Hiroshi; Sconocchia, Giuseppe; Melenhorst, Jan J; Hensel, Nancy; Marti, Gerald E; Kwak, Larry W; Wilson, Wyndham; Barrett, John A.

Clin Cancer Res; 10(3): 1047-56, 2004 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-14871984

18.

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.

Porter, David L; Hwang, Wei-Ting; Frey, Noelle V; Lacey, Simon F; Shaw, Pamela A; Loren, Alison W; Bagg, Adam; Marcucci, Katherine T; Shen, Angela; Gonzalez, Vanessa; Ambrose, David; Grupp, Stephan A; Chew, Anne; Zheng, Zhaohui; Milone, Michael C; Levine, Bruce L; Melenhorst, Jan J; June, Carl H.

Sci Transl Med; 7(303): 303ra139, 2015 Sep 02.

Artículo en Inglés | MEDLINE | ID: mdl-26333935

19.

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.

Hanley, Patrick J; Melenhorst, Jan J; Nikiforow, Sarah; Scheinberg, Phillip; Blaney, James W; Demmler-Harrison, Gail; Cruz, C Russell; Lam, Sharon; Krance, Robert A; Leung, Kathryn S; Martinez, Caridad A; Liu, Hao; Douek, Daniel C; Heslop, Helen E; Rooney, Cliona M; Shpall, Elizabeth J; Barrett, A John; Rodgers, John R; Bollard, Catherine M.

Sci Transl Med; 7(285): 285ra63, 2015 Apr 29.

Artículo en Inglés | MEDLINE | ID: mdl-25925682

20.

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Sotillo, Elena; Barrett, David M; Black, Kathryn L; Bagashev, Asen; Oldridge, Derek; Wu, Glendon; Sussman, Robyn; Lanauze, Claudia; Ruella, Marco; Gazzara, Matthew R; Martinez, Nicole M; Harrington, Colleen T; Chung, Elaine Y; Perazzelli, Jessica; Hofmann, Ted J; Maude, Shannon L; Raman, Pichai; Barrera, Alejandro; Gill, Saar; Lacey, Simon F; Melenhorst, Jan J; Allman, David; Jacoby, Elad; Fry, Terry; Mackall, Crystal; Barash, Yoseph; Lynch, Kristen W; Maris, John M; Grupp, Stephan A; Thomas-Tikhonenko, Andrei.

Cancer Discov; 5(12): 1282-95, 2015 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-26516065

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: